Table 2.
Baseline | Post-Intervention | Follow-up | ||||
---|---|---|---|---|---|---|
Intervention | Control | Intervention | Control | Intervention | Control | |
MAL-14 | ||||||
AOU * | 2.0 (± 1.1) | 1.9 (± 1.2) | 2.1 (± 1.2) | 2.0 (± 1.2) | 2.3 (± 1.1) | 2.0 (± 1.2) |
QOM * | 1.7 (± 0.9) | 1.6 (± 1.2) | 1.9 (± 1.0) | 1.8 (± 1.2) | 2.0 (± 1.0) | 1.8 (± 1.2) |
FMA-UE * |
35.6 (± 14.8) |
34.7 (± 14.9) |
37.2 (± 16.2) |
35.8 (± 15.4) |
37.3 (± 15.4) |
35.6 (± 14.9) |
ARAT * |
31.0 (± 18.1) |
29.5 (± 18.8) |
32.5 (± 19.3) |
31.6 (± 18.8) |
33.7 (± 19.4) |
32.0 (± 18.6) |
mRS | 2.5 (± 0.5) | 2.7 (± 0.8) | 2.5 (± 0.5) | 2.7 (± 0.8) | 2.5 (± 0.5) | 2.7 (± 0.8) |
EQ-5D-5 L | ||||||
Index value | 0.8 (± 0.1) | 0.8 (± 0.2) | 0.8 (± 0.1) | 0.8 (± 0.2) | 0.8 (± 0.1) | 0.8 (± 0.2) |
VAS |
66.5 (± 15.0) |
65.0 (± 7.0) |
65.6 (± 16.3) |
69.4 (± 16.7) |
67.8 (± 16.2) |
64.7 (± 20.5) |
GRPC | ||||||
Affected arm use | 4.7 (± 1.1) | 5.1 (± 1.2) | 4.7 (± 1.0) | 4.7 (± 1.3) | ||
Physical activity | 4.9 (± 0.8) | 5.1 (± 0.9) | 4.9 (± 1.0) | 4.8 (± 1.2) |